Baculovirus expression of two human recombinant neutralizing IgG monoclonal antibodies to hepatitis A virus / 中华实验和临床病毒学杂志
Jing-yuan CAO; Mi-fang LIANG; Qing-ling MENG; Xiao-fang WANG; Yong-gang XU; Ke-qian GUO; Mei-yun ZHAN; Sheng-li BI; De-xin LI.
Chinese Journal of Experimental and Clinical Virology
; (6): 20-23, 2004.
Artículo
en Zh
| WPRIM | ID: wpr-281816
<p><b>OBJECTIVE</b>To develop human recombinant neutralizing IgG monoclonal antibodies to hepatitis A virus (HAV) by baculovirus expression system.</p><p><b>METHODS</b>The heavy and light chain genes of two human-derived neutralizing Fab antibodies to HAV were cloned into baculovirus expression vector Pac-kappa-Fc and Pac-L-Fc, and further expressed in insect cells as IgG antibodies. The IgG products were purified and well characterized.</p><p><b>RESULTS</b>The baculovirus expressed McAb HAFc16 fully retained the specificity of binding to hepatitis A virus and the competition with mouse anti-hepatitis A virus McAb using ELISA. The viral neutralization assay in vitro demonstrated the retention of antibody function after expression of the human antibody in insect cells. The other expressed antibody HAFc78 also has the neutralizing activity but it is directed against different epitopes of HAV when compared with HAFc16.</p><p><b>CONCLUSION</b>The recombinant baculovirus/insect cells expressed human neutralizing IgG antibodies to hepatitis A virus retained all biological functions specific for hepatitis A virus. The results provided the possibility of using these antibodies to rapidly protect high risk or early exposure populations from hepatitis A virus infection.</p>
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados